Last $22.19 USD
Change Today +0.76 / 3.55%
Volume 2.6M
EXAS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stanley N. Lapidus

AgeTotal Calculated CompensationThis person is connected to 77 board members in 7 different organizations across 10 different industries.

See Board Relationships
65--

Background*

Mr. Stanley N. Lapidus, also known as Stan, is a Co-Founder of SynapDx Corporation and serves as its President and Chief Executive Officer. Mr. Lapidus is a Co-Founder and served as the Chief Executive Officer of Helicos Biosciences Corporation. He serves as an Advisor of the Harvard MIT Division of Health Services and Technology. Mr. Lapidus has been Research Assistant Professor in the Pathology Department of Tufts University Medical School, Boston since 1994. He serves ...

Read Full Background

Corporate Headquarters*

441 Charmany Drive
Madison, Wisconsin 53719

United States

Phone: 608-284-5700
Fax: 608-284-5701

Board Members Memberships*

Director
Former Director
Co-Founder
Former Director
Director
Co-Founder, Chief Executive Officer, President and Director
1995-2006
Founder
2001-Present
Chairman of the Board
2008-Present
Director and Chairman of Compensation Committee

Education*

BS
Cooper Union for the Advancement of Science and Art, The

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $22.19 USD +0.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Michael M. Goldberg M.D., M.B.A.Interim Chief Executive Officer and Director
Navidea Biopharmaceuticals, Inc
--
Rosemary A. Crane Chief Executive Officer, President and Director
MELA Sciences, Inc.
$43.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.